Trial intelligence / Profile preview

Asthma Control with FP/Salmeterol vs FP Using BHR Guide

NCT00920543Phase 4Completed

Sponsor
GSK
Start
Feb 2003
Primary completion
Oct 2004
Modality
Small Molecules
Countries
4
01

Overview

A Phase 4 trial of salmeterol in asthma, sponsored by GSK. Started Feb 2003; status: completed.

02

Drugs

salmeterol
03

Conditions

asthma

Beyond the preview

Go deeper on NCT00920543.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00920543.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call